» Articles » PMID: 28536263

Axodendritic Sorting and Pathological Missorting of Tau Are Isoform-specific and Determined by Axon Initial Segment Architecture

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 May 25
PMID 28536263
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Subcellular mislocalization of the microtubule-associated protein Tau is a hallmark of Alzheimer disease (AD) and other tauopathies. Six Tau isoforms, differentiated by the presence or absence of a second repeat or of N-terminal inserts, exist in the human CNS, but their physiological and pathological differences have long remained elusive. Here, we investigated the properties and distributions of human and rodent Tau isoforms in primary forebrain rodent neurons. We found that the Tau diffusion barrier (TDB), located within the axon initial segment (AIS), controls retrograde (axon-to-soma) and anterograde (soma-to-axon) traffic of Tau. Tau isoforms without the N-terminal inserts were sorted efficiently into the axon. However, the longest isoform (2N4R-Tau) was partially retained in cell bodies and dendrites, where it accelerated spine and dendrite growth. The TDB (located within the AIS) was impaired when AIS components (ankyrin G, EB1) were knocked down or when glycogen synthase kinase-3β (GSK3β; an AD-associated kinase tethered to the AIS) was overexpressed. Using superresolution nanoscopy and live-cell imaging, we observed that microtubules within the AIS appeared highly dynamic, a feature essential for the TDB. Pathomechanistically, amyloid-β insult caused cofilin activation and F-actin remodeling and decreased microtubule dynamics in the AIS. Concomitantly with these amyloid-β-induced disruptions, the AIS/TDB sorting function failed, causing AD-like Tau missorting. In summary, we provide evidence that the human and rodent Tau isoforms differ in axodendritic sorting and amyloid-β-induced missorting and that the axodendritic distribution of Tau depends on AIS integrity.

Citing Articles

-A152T mutation drives neuronal hyperactivity through Fyn-NMDAR signaling in human iPSC-Derived neurons: Insights into Alzheimer's pathogenesis.

Itsuno M, Tanabe H, Sano E, Sasaki T, Oyama C, Bannai H Regen Ther. 2025; 28():201-213.

PMID: 39811068 PMC: 11730958. DOI: 10.1016/j.reth.2024.12.009.


Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons.

Breuer H, Bell-Simons M, Zempel H Open Life Sci. 2025; 19(1):20221010.

PMID: 39759106 PMC: 11699562. DOI: 10.1515/biol-2022-1010.


Amyloid-β-induced disruption of axon-initial-segment mitochondria localization: consequences for TAU missorting in Alzheimer's disease pathology.

Adam D, Langerscheidt F, Zempel H Neural Regen Res. 2024; 20(5):1407-1408.

PMID: 39075906 PMC: 11624863. DOI: 10.4103/NRR.NRR-D-24-00253.


Cellular and pathological functions of tau.

Bravo C, Naguib S, Gan L Nat Rev Mol Cell Biol. 2024; 25(11):845-864.

PMID: 39014245 DOI: 10.1038/s41580-024-00753-9.


Directionality bias underpins divergent spatiotemporal progression of Alzheimer-related tauopathy in mouse models.

Torok J, Mezias C, Raj A bioRxiv. 2024; .

PMID: 38895243 PMC: 11185722. DOI: 10.1101/2024.06.04.597478.


References
1.
Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E . Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 2013; 32(22):2920-37. PMC: 3831312. DOI: 10.1038/emboj.2013.207. View

2.
Andreadis A . Tau splicing and the intricacies of dementia. J Cell Physiol. 2011; 227(3):1220-5. PMC: 3177961. DOI: 10.1002/jcp.22842. View

3.
Goedert M, Ghetti B, Spillantini M . Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 2(2):a006254. PMC: 3281593. DOI: 10.1101/cshperspect.a006254. View

4.
Zempel H, Mandelkow E . Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 2014; 37(12):721-32. DOI: 10.1016/j.tins.2014.08.004. View

5.
Dickson D, Kouri N, Murray M, Josephs K . Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci. 2011; 45(3):384-9. PMC: 3208128. DOI: 10.1007/s12031-011-9589-0. View